FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, specifically to the use M. vaccae for the prevention of post-traumatic stress disorder (PTSD). Use of M. vaccae for the prevention of PTSD and symptoms associated with such a disorder. Use of M. vaccae for administration to a subject to prevent the rising of IL-6 levels in a subject after exposure to a traumatic event.
EFFECT: above-described invention can prevent or significantly reduce the effect of PTSD.
16 cl, 5 dwg, 1 ex
